Patent Assignment
Reel/Frame 071893/0897
Change of Name
Recorded: 2025-07-10
Pages: 4
Assignor
NETHERLANDS TRANSLATIONAL RESEARCH CENTER HOLDING B.V.
Executed: 2023-09-11
Assignee
CROSSFIRE ONCOLOGY HOLDING B.V.
KLOOSTERSTRAAT 9, AB OSS, 5349, NETHERLANDS
Covered Properties
(5)
(5,6-Dihydro)Pyrimido[4,5-E]Indolizines
Prognostic Biomarkers for Ttk Inhibitor Chemotherapy
(5,6-Dihydro)Pyrimido[4,5-E]Indolizines
Patent:
48,974 →
Application:
16/728,900 →
Prognostic Biomarkers for Ttk Inhibitor Chemotherapy
(5,6-Dihydro)Pyrimido[4,5-E]Indolizines
Patent:
50,082 →
Application:
17/579,990 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 23, 2016
From: DE MAN, ADRIANUS PETRUS ANTONIUS; BUIJSMAN, ROGIER CHRISTIAN; STERRENBURG, JAN GERARD; UITDEHAAG, JOOST CORNELIS MARINUS
To: NETHERLANDS TRANSLATIONAL RESEARCH CENTER B.V.
Reel/Frame 040138/0808 →
Corrective Assignment to Correct the Execution Date of 3RD Inventor Previously Recorded on Reel 040138 Frame 0808. Assignor(S) Hereby Confirms the Assignment.
Nov 8, 2016
From: DE MAN, ADRIANUS PETRUS ANTONIUS; BUIJSMAN, ROGIER CHRISTIAN; STERRENBURG, JAN GERARD; UITDEHAAG, JOOST CORNELIS MARINUS
To: NETHERLANDS TRANSLATIONAL RESEARCH CENTER B.V.
Reel/Frame 040614/0799 →
Assignment of Assignor's Interest
Nov 22, 2017
From: DE ROOS, JEROEN; UITDEHAAG, JOOST CORNELIS MARINUS; DE MAN, ADRIANUS PETRUS ANTONIUS; BUIJSMAN, ROGIER CHRISTIAAN
To: NETHERLANDS TRANSLATIONAL RESEARCH CENTER B.V.
Reel/Frame 044803/0764 →
Assignment of Assignor's Interest
Jul 10, 2025
From: CROSSFIRE ONCOLOGY HOLDING B.V.
To: SILLAJEN INC.
Reel/Frame 071657/0279 →